Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

LAT

Previous Assay Next Assay
Available Assays

Overview Data source: UniProt

Official Gene Symbol Other Aliases
LAT N/A
Sequence Length (AA) Molecular Weight (Da)
262 27930
Protein Name
Linker for activation of T-cells family member 1
Sources
UniProt
PhosphoSitePlus ®
GeneCards 		Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MEEAILVPCV LGLLLLPILA MLMALCVHCH RLPGSYDSTS SDSLYPRGIQ
60 70 80 90 100
FKRPHTVAPW PPAYPPVTSY PPLSQPDLLP IPRSPQPLGG SHRTPSSRRD
110 120 130 140 150
SDGANSVASY ENEGASGIRG AQAGWGVWGP SWTRLTPVSL PPEPACEDAD
160 170 180 190 200
EDEDDYHNPG YLVVLPDSTP ATSTAAPSAP ALSTPGIRDS AFSMESIDDY
210 220 230 240 250
VNVPESGESA EASLDGSREY VNVSQELHPG AAKTEPAALS SQEAEEVEEE
260 262
GAPDYENLQE LN

Data source: UniProt

Protein Map Collapse protein map

Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-5889 Collapse assay details

Data source: Panorama

Official Gene Symbol
LAT
Peptide Modified Sequence
EYVNVS[+79.966331]QELHPGAAK
Modification Type
Phospho (ST)
Protein - Site of Modification
225
Peptide - Site of Modification
6
Peptide Start
219
Peptide End
233
CPTAC ID
CPTAC-5889
Peptide Molecular Mass
1,720.7822
Species
Homo sapiens (Human)
Assay Type
Enrichment MRM
Enrichment Method
peptide immunoaffinity
Matrix
Cell Lysate
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Cancers (Basel). 2021 Jul 30;13(15):3843. doi: 10.3390/cancers13153843. PMID: 34359745

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Sciex 5500 QTRAP
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Eksigent 425
Column Packing
Reprosil
Column Dimensions
75um x 15cm
Flow Rate
300 nL/min

Chromatograms

Data source: Panorama

view larger image
view larger image
view larger image

Response Curves

Data source: Panorama

view larger image
view larger image
view larger image

Retrieving Data

Loader

Repeatability

Data source: Panorama

view larger image
  Average intra-assay CV
(within day CV)		 Average inter-assay CV
(between day CV)		 Total CV
equation		 n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y10 (2+) 11 6.7 3.2 19.4 16.4 10.2 22.3 17.7 10.7 15 27 15
y11-98 (2+) 12.9 6.5 3.8 22.8 15 15.5 26.2 16.3 16 15 27 15
y12-98 (2+) 13.7 6.4 5.6 18.6 15.6 16.8 23.1 16.9 17.7 15 27 15
y12 (2+) 11.4 6 5.3 23.9 16.5 14.6 26.5 17.6 15.5 15 27 15
y13-98 (2+) 14.4 7.8 5.9 27.4 16.9 13.2 31 18.6 14.5 15 27 15
y5 (1+) 8.7 6.2 4.9 16.8 17 13.3 18.9 18.1 14.2 15 27 15
y13 (3+) 14.4 8.5 5 17.4 13.1 11.9 22.6 15.6 12.9 15 27 15
sum 3.9 3 2.8 16.3 14.9 12.8 16.8 15.2 13.1 15 27 15

Additional Resources and Comments

Resources
Download SOPs
View Peptide in Panorama
View Protein in Panorama
View in CPTC Antibody Portal
Comments